Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe.
Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain.
Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.
Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.
Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3.
All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.
Determinants of High Cost in Multiple Sclerosis Patients: A Claims and Chart Review Study.
The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.
The relationship between static posturography measures and specific cognitive domains in individuals with multiple sclerosis.
A rare case of SPG11 mutation with multiple sclerosis.
Cognitive Impairment and Health Related Quality of Life in Relapsing Remitting Multiple Sclerosis.
The Efficacy of Functional Electrical Stimulation of the Abdominal Muscles in the Treatment of Chronic Constipation in Patients with Multiple Sclerosis: A Pilot Study.
A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.
Short Term Reproducibility of a High Contrast 3-D Isotropic Optic Nerve Imaging Sequence in Healthy Controls.
Translational challenge models in support of efficacy studies: Neurobehavioral and cognitive changes induced by Transcranial Magnetic Stimulation in healthy volunteers.
Sodium intake is associated with increased disease activity in multiple sclerosis.
Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5-5.0).
The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech Republic.
Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy.
Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Evaluation of chronic inflammatory demyelinating polyneuropathy: 3D nerve-sheath signal increased with inked rest-tissue rapid acquisition of relaxation enhancement imaging (3D SHINKEI).
Minimally Invasive En Bloc Resection of Massive Obstructive Atrial Tumour.
A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus.
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.

Pages